Abstract
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of central nervous system of unknown etiology. However, some infectious agents have been suggested to play a significant role in its pathogenesis. Next-generation sequencing (NGS) and metagenomics can be employed to characterize microbiome of MS patients and to identify potential causative pathogens. In this study, 12 patients with idiopathic inflammatory demyelinating disorders (IIDD) of the central nervous system were studied: one patient had clinically isolated syndrome, one patient had recurrent optic neuritis, and ten patients had multiple sclerosis (MS). In addition, there was one patient with other non-inflammatory neurological disease. Cerebrospinal fluid (CSF) was sampled from all patients. RNA was extracted from CSF and subjected to a single-primer isothermal amplification followed by NGS and comprehensive data analysis. Altogether 441,608,474 reads were obtained and mapped using blastn. In a CSF sample from the patient with clinically isolated syndrome, 11 varicella-zoster virus reads were found. Other than that similar bacterial, fungal, parasitic, and protozoan reads were identified in all samples, indicating a common presence of contamination in metagenomics. In conclusion, we identified varicella zoster virus sequences in one out of the 12 patients with IIDD, which suggests that this virus could be occasionally related to the MS pathogenesis. A widespread bacterial contamination seems inherent to NGS and complicates the interpretation of results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61(6):504–513
Benito-Leon J, Pisa D, Alonso R, Calleja P, Diaz-Sanchez M, Carrasco L (2010) Association between multiple sclerosis and Candida species: evidence from a case-control study. Eur J Clin Microbiol Infect Dis 29(9):1139–1145
Borkosky SS, Whitley C, Kopp-Schneider A, zur Hausen H, de Villiers EM (2012) Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis. PLoS ONE 7(2):e32160. doi:10.1371/journal.pone.0032160
Brahic M (2010) Multiple sclerosis and viruses. Ann Neurol 68(1):6–8
Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, Venkatesan A, Fraser CM, Mowry EM (2015) Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med 63(5):729–734
Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15:532–537
FASTX-Toolkit (2016) FASTQ/A short-reads pre-processing tools. http://hannonlab.cshl.edu/fastx_toolkit/index.html. Accessed on 11 April 2016
Goto N, Prins P, Nakao M, Bonnal R, Aerts J, Katayama T (2010) BioRuby: bioinformatics software for the Ruby programming language. Bioinformatics 26(20):2617–2619
Hansen JJ (2015) Immune responses to intestinal microbes in inflammatory bowel diseases. Curr Allergy Asthma Rep 15(10):562. doi:10.1007/s11882-015-0562-9
Hughes LE, Bonell S, Natt RS, Wilson C, Tiwana H, Ebringer A, Cunningham P, Chamoun V, Thompson EJ, Croker J, Vowles J (2001) Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-acinetobacter-neurofilament antibody index. Clin Diagn Lab Immunol 8(6):1181–1188
Joscelyn J, Kasper LH (2014) Digesting the emerging role for the gut microbiome in central nervous system demyelination. Mult Scler 20(12):1553–1559
Kakalacheva K, Munz C, Lunemann JD (2011) Viral triggers of multiple sclerosis. Biochim Biophys Acta 1812(2):132–140
Krametter D, Niederwieser G, Berghold A, Birnbaum G, Strasser-Fuchs S, Hartung HP, Archelos JJ (2001) Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler 7(1):13–18
Laurence M, Hatzis C, Brash DE (2014) Common contaminants in next-generation sequencing that hinder discovery of low-abundance microbes. PLoS ONE 9(5):e97876. doi:10.1371/journal.pone.0097876
Lunter G, Goodson M (2011) Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res 21(6):936–939
Mancuso R, Delbue S, Borghi E, Pagani E, Calvo MG, Caputo D, Granieri E, Ferrante P (2007) Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol 79(2):192–199
Marrie RA (2004) Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3(12):709–718
Martin M (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. 17(1); doi: 10.14806/ej.17.1.200
Miller RR, Montoya V, Gardy JL, Patrick DM, Tang P (2013) Metagenomics for pathogen detection in public health. Genome Med 5(9):81. doi:10.1186/gm485
Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, Morita H, Hattori M, Yamamura T (2015) Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS ONE 10(9):e0137429. doi:10.1371/journal.pone.0137429
Norrby E, Link H, Olsson JE (1974) Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum. Arch Neurol 30(4):285–292
O’Gorman C, Lucas R, Taylor B (2012) Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci 13(9):11718–11752
Ordonez G, Pineda B, Garcia-Navarrete R, Sotelo J (2004) Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis. Arch Neurol 61(4):529–532
Padmanabhan R, Mishra AK, Raoult D, Fournier PE (2013) Genomics and metagenomics in medical microbiology. J Microbiol Methods 95(3):415–424
Pender MP, Burrows SR (2014) Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin Transl Immunol 3(10):e27. doi:10.1038/cti.2014.25
Perlejewski K, Popiel M, Laskus T, Nakamura S, Motooka D, Stokowy T, Lipowski D, Pollak A, Lechowicz U, Caraballo Cortés K, Stępień A, Radkowski M, Bukowska-Osko I (2015) Next-generation sequencing (NGS) in the identification of encephalitis-causing viruses: unexpected detection of human herpesvirus 1 while searching for RNA pathogens. J Virol Methods 226:1–6
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302
Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313–323
Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW (2014) Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 12:87. doi:10.1186/s12915-014-0087-z
Sanders VJ, Waddell AE, Felisan SL, Li X, Conrad AJ, Tourtellotte WW (1996) Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch Neurol 53(2):125–133
Sleator RD, Shortall C, Hill C (2008) Metagenomics. Lett Appl Microbiol 47(5):361–366
Sotelo J, Martinez-Palomo A, Ordonez G, Pineda B (2008) Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis. Ann Neurol 63(3):303–311
Sotelo J, Ordonez G, Pineda B, Flores J (2014) The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg 119:44–48
Swanborg RH, Whittum-Hudson JA, Hudson AP (2003) Infectious agents and multiple sclerosis–are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol 136(1–2):1–8
Weiss S, Amir A, Hyde ER, Metcalf JL, Song SJ, Knight R (2014) Tracking down the sources of experimental contamination in microbiome studies. Genome Biol 15(12):564. doi:10.1186/s13059-014-0564-2
Zawada M (2012) Potential pathogens in multiple sclerosis (MS). Postepy Hig Med Dosw (Online) 66:758–770
Zivadinov R, Nasuelli D, Tommasi MA, Serafin M, Bratina A, Ukmar M, Pirko I, Johnson AJ, Furlan C, Pozzi-Mucelli RS, Monti-Bragadin L, Grop A, Zambon M, Antonello RM, Cazzato G, Zorzon M (2006) Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res 28(3):262–269
Acknowledgment
This study was supported by grants from the Foundation for Polish Science – 67/UD/SKILLS/2014 and the Polish National Science Center – N/N401/646940.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Perlejewski, K. et al. (2016). Metagenomic Analysis of Cerebrospinal Fluid from Patients with Multiple Sclerosis. In: Pokorski, M. (eds) Pulmonary Infection and Inflammation. Advances in Experimental Medicine and Biology(), vol 935. Springer, Cham. https://doi.org/10.1007/5584_2016_25
Download citation
DOI: https://doi.org/10.1007/5584_2016_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44484-0
Online ISBN: 978-3-319-44485-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)